title: Regulation of a Ca2+-activated K+ channel by calcium-sensing receptor involves p38 MAP kinase.
abstract: By using pharmacological and molecular approaches, we previously showed that the G-protein-coupled, extracellular calcium (Ca2+(o))-sensing receptor (CaR) regulates a large-conductance (approximately 140 pS), Ca(2+)-activated K+ channel [IK(Ca); CAKC] in U87 astrocytoma cells. Here we show that elevated Ca2+(o) stimulates extracellular-signal-regulated kinase (ERK1/2) and p38 MAP kinase (MAPK). The effect of high Ca2+(o) on p38 MAPK but not ERK1/2 is CaR mediated, insofar as transduction with a dominant-negative CaR (R185Q) using recombinant adeno-associated virus (rAAV) attenuated the activation of p38 MAPK but not of ERK1/2. p38 MAPK activation by the CaR is likely to be protein kinase C (PKC) independent, in that the pan-PKC inhibitor GF109203X failed to abolish the high-Ca2+(o)-induced phosphorylation of p38 MAPK. Consistently with our data on the activation of this kinase, we observed that inhibiting p38 MAPK blocked the activation of the CAKC induced by the specific pharmacological CaR activator NPS R-467. In contrast, inhibiting MEK1 only transiently inhibited the activation of this K+ channel by NPS R-467, despite the continued presence of the antagonist. Similarly to the lack of any effect of the PKC inhibitor on the activation of ERK1/2 and p38 MAPK, inhibiting PKC had no effect on NPS R-467-induced activation of this channel. Therefore, our data show that the CaR, acting via p38 MAPK, regulates a large-conductance CAKC in U87 cells, a process that is PKC independent. Large-conductance CAKCs play an important role in the regulation of cellular volume, so our results have important implications for glioma cell volume regulation.
authors.affiliation: Division of Endocrinology, Hypertension and Diabetes and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. cye@rics.bwh.harvard.edu
authors.forename: Chian Ping
authors.initials: CP
authors.lastname: Ye
authors.forename: Shozo
authors.initials: S
authors.lastname: Yano
authors.forename: Jacob
authors.initials: J
authors.lastname: Tfelt-Hansen
authors.forename: R John
authors.initials: RJ
authors.lastname: MacLeod
authors.forename: Xianghui
authors.initials: X
authors.lastname: Ren
authors.forename: Ernest
authors.initials: E
authors.lastname: Terwilliger
authors.forename: Edward M
authors.initials: EM
authors.lastname: Brown
authors.forename: Naibedya
authors.initials: N
authors.lastname: Chattopadhyay
mesh_terms: D002118:Calcium / Q000494:pharmacology; D045744:Cell Line, Tumor; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D024681:Potassium Channels, Calcium-Activated / Q000819:agonists / Q000502:physiology*; D044169:Receptors, Calcium-Sensing / Q000819:agonists / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases
chemical_list: D024681:Potassium Channels, Calcium-Activated; D044169:Receptors, Calcium-Sensing; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases; D002118:Calcium